Question-and-Answer Session
Operator
(Operator Instructions) Our first question comes from Anthony Vendetti from Maxim Group.
Anthony Vendetti - Maxim Group
I want to, just get an update on the cellulite product. I know that that was pushed out a little bit. Do you have any update on that? Then if you could talk about just in very broad terms where you see the opportunities over the next couple of years in terms of the development pipeline?
Gerard Puorro
Well in terms of cellulite specifically as they relate to Candela, was if you remember we had pushed it out. We originally said like the end of the calendar year and we said, we saw some slips in there and pushed it into the earlier part of 2010. As part of the merger activities, we are going to all of the product positioning and product rationalization and we have been for the past five weeks of various integration teams. There were a number of products that the Syneron folks have, related to body shaping and so on.
So we need to position our cellulite product in that and in due course, we will be talking to people about the positioning. There is an awful lot of shows coming up, this AMCAS in January and EAD in March and [ASEM] in April. We will be telling people more about how we position, not only the products that are in the market together but the products that are in each other’s pipelines together and other than that, I do not want to talk about the specificity of the R & D pipelines right now, okay?
Anthony Vendetti - Maxim Group
Yes that is fair. Can you talk, Gerry, just a little bit about since you said you spent about five weeks in the integration process already, can you talk about how that is going? What you have learned in the integration process? Is it ahead of schedule? Is it moving as you expected? Any insights you can share will be great.
Gerard Puorro
Well it is very, very positive. M&A transactions historically are really, really hard to do and difficult and I am sure there are skeptics out there, given that one firm is Israeli and the other is a U.S. based firm. You know Shimon Eckhouse and I have been in this industry over two decades together, we have known each other and we are trying--and Louis P. Scafuri as well was in the industry for years.
- To read the full transcript on Seeking Alpha, click here »
